InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: noradio post# 35305

Sunday, 10/18/2020 12:14:41 AM

Sunday, October 18, 2020 12:14:41 AM

Post# of 198610
Well said! It is indeed a "Reverse Merger" transaction, which is also commonly referred to as an Acquisition!


Here's the definition of what we are about to see happen between Enzolytics and BioClonetics....

What is a Reverse Merger?

Definition:

A Reverse Merger is when a Private Company (BioClonetics) goes public by acquiring an already-public Company (Enzolytics).

This is referred to as a "Reverse Merger" because it's less common for a private company to acquire a public company." Generally it's the opposite!

Simply put, BioClonetics is acquiring Enzolytics!

It is also possible post-reverse merger, that the new entity will be accompanied by a name change, as is the case also for any merger, OR the new company Board made up of the principals of both companies could decide to maintain the name of the already public company (Ezolytics).

Overall, the merger adds significant increase value to the underlying stock of the public company (Enzolytics) due to the existing substantial valuation of the acquiring company aka: "parent company" (BioClonetics).

IMO, I fully anticipate that upon post-merger, Enzolytic's stock price will increase significantly and gradually rise thereafter as more developments occur all the way to pharmaceutical commercialization of its Clone-3 Patent.


Be well and prosper ...